DOSSIER · 13F-HR · Q4 2025

NVP Associates, LLC

$255M in tracked AUM across 6 positions as of Q4 2025.

NA
CIK 0001545692 · last filed Dec 31, 2025
Total AUM
$255M
as of Q4 2025
Holdings
6
positions
Whale Score
65
65
tracked
Activity
no data
changes this Q
AI Analysis · Q4 2025

Portfolio Overview

NVP Associates, LLC presents a highly concentrated, high-conviction investment portfolio characterized by low turnover and significant exposure to small-cap and micro-cap growth companies. As of the reporting period ending September 30, 2025, the firm managed approximately $166.05 million across just 5 holdings. The portfolio experienced a decrease in value of 9.8% (down from $184.15 million in the previous quarter), a decline driven by a combination of market...

The portfolio structure is extremely top-heavy, with the top three holdings—Omada Health, Zenas Biopharma, and MBX Biosciences—accounting for approximately 80.8% of the total assets. This lack of broad diversification suggests an investment philosophy that prioritizes specific stock selection over broad market exposure or risk mitigation through sector spreading. The firm appears to operate as a specialized investor willing to take outsized risks on a select few companies.

Key Holdings

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
MBX
MBX BIOSCIENCES INC
$67M2.1M26.4%
02
ZBIO
ZENAS BIOPHARMA INC
$67M1.8M26.2%
03
BLLN
BILLIONTOONE INC
$42M513K16.5%
04
OMDA
OMADA HEALTH INC
$40M2.5M15.6%
05
TALK
TALKSPACE INC
$36M9.8M13.9%
06
GROV
GROVE COLLABORATIVE HOLD INC
$4M3.2M1.4%

Filing history

2025Q4Dec 31
$255M 53.7%
6 positionsView →
2025Q3Sep 30
$166M 9.8%
5 positionsView →
2025Q2Jun 30
$184M 70.7%
7 positionsLocked
2025Q1Mar 31
$108M 42.3%
5 positionsLocked
2024Q4Dec 31
$187M 6.1%
7 positionsLocked
2024Q3Sep 30
$176M 93.0%
8 positionsLocked
2024Q2Jun 30
$91M 27.5%
6 positionsLocked
2024Q1Mar 31
$126M 12.4%
6 positionsLocked
2023Q4Dec 31
$112M 0.4%
6 positionsLocked
2023Q3Sep 30
$112M 2.6%
8 positionsLocked
2023Q2Jun 30
$115M 31.9%
9 positionsLocked
2023Q1Mar 31
$87M 15.2%
8 positionsLocked
Showing 12 of 13